• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有酪氨酸官能化的5,5-双环噻唑并双环烷二肽模拟物的AT2选择性血管紧张素II类似物。

AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.

作者信息

Johannesson Petra, Erdélyi Máté, Lindeberg Gunnar, Frändberg Per-Anders, Nyberg Fred, Karlén Anders, Hallberg Anders

机构信息

Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden.

出版信息

J Med Chem. 2004 Nov 18;47(24):6009-19. doi: 10.1021/jm049651m.

DOI:10.1021/jm049651m
PMID:15537355
Abstract

This paper reports the synthesis of two angiotensin II analogues with tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics replacing the Tyr(4)-Ile(5) residues. The preparation of these analogues relies on the synthesis and incorporation of an alpha,alpha-disubstituted chimeric amino acid derivative and on-resin bicyclization to a cysteine residue. The synthesized analogues both displayed high angiotensin AT(2)/AT(1) receptor binding preferences and had AT(2) receptor affinities in the same low nanomolar range as angiotensin II itself. Conformational analysis, using experimental constraints derived from NMR studies, indicated that the Tyr(4) and His(6) residues in one of the angiotensin II analogues were in close proximity to each other.

摘要

本文报道了两种血管紧张素II类似物的合成,其酪氨酸功能化的5,5-双环噻唑并双环烷二肽模拟物取代了Tyr(4)-Ile(5)残基。这些类似物的制备依赖于α,α-二取代嵌合氨基酸衍生物的合成与掺入以及与半胱氨酸残基的树脂上双环化。合成的类似物均表现出对血管紧张素AT(2)/AT(1)受体的高结合偏好,且对AT(2)受体的亲和力与血管紧张素II本身处于相同的低纳摩尔范围。利用源自核磁共振研究的实验约束进行的构象分析表明,其中一种血管紧张素II类似物中的Tyr(4)和His(6)残基彼此靠近。

相似文献

1
AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.含有酪氨酸官能化的5,5-双环噻唑并双环烷二肽模拟物的AT2选择性血管紧张素II类似物。
J Med Chem. 2004 Nov 18;47(24):6009-19. doi: 10.1021/jm049651m.
2
Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics.包含5,9-和5,10-稠合噻唑双环烷烃三肽模拟物的血管紧张素II类似物。
J Med Chem. 1999 Nov 4;42(22):4524-37. doi: 10.1021/jm991089q.
3
Bicyclic tripeptide mimetics with reverse turn inducing properties.具有诱导β-转角性质的双环三肽模拟物。
J Med Chem. 1999 Feb 25;42(4):601-8. doi: 10.1021/jm981077p.
4
Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.含有具有高AT2受体亲和力的1,3,5-三取代苯支架的血管紧张素II假肽。
J Med Chem. 2005 Oct 20;48(21):6620-31. doi: 10.1021/jm050280z.
5
A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.一种选择性AT2受体配体,具有类似γ-转角的模拟物,取代了血管紧张素II的4-5位氨基酸残基。
J Med Chem. 2004 Feb 12;47(4):859-70. doi: 10.1021/jm030921v.
6
New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.包含γ-转角模拟物以取代血管紧张素II的4-5位氨基酸残基的新型选择性AT2受体配体可作为激动剂。
J Med Chem. 2005 Jun 16;48(12):4009-24. doi: 10.1021/jm0491492.
7
Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.
J Med Chem. 2006 Oct 5;49(20):6133-7. doi: 10.1021/jm051222g.
8
Conformationally constrained CCK4 analogues incorporating IBTM and BTD beta-turn mimetics.包含异苯并噻唑啉酮(IBTM)和苯并噻二唑(BTD)β-转角模拟物的构象受限CCK4类似物。
J Med Chem. 2005 Dec 1;48(24):7667-74. doi: 10.1021/jm050689o.
9
Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
J Med Chem. 2007 Apr 5;50(7):1711-5. doi: 10.1021/jm0613469. Epub 2007 Mar 15.
10
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.含有具有高AT2受体亲和力的转角支架的短假肽。
Bioorg Med Chem. 2006 Sep 1;14(17):5963-72. doi: 10.1016/j.bmc.2006.05.019. Epub 2006 Jun 5.

引用本文的文献

1
The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.血管紧张素 AT 受体:从结合位点到新的治疗靶点。
Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281.
2
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2.与血管紧张素转换酶 2(ACE2)和血管紧张素受体 1 和 2 结合的结构决定因素。
Front Pharmacol. 2015 Jan 30;6:5. doi: 10.3389/fphar.2015.00005. eCollection 2015.
3
Update on the angiotensin AT(2) receptor.血管紧张素 AT(2)受体的最新研究进展。
Curr Hypertens Rep. 2013 Feb;15(1):25-30. doi: 10.1007/s11906-012-0321-4.
4
AT2 receptors: functional relevance in cardiovascular disease.血管紧张素Ⅱ 2型受体:在心血管疾病中的功能相关性
Pharmacol Ther. 2008 Dec;120(3):292-316. doi: 10.1016/j.pharmthera.2008.08.009. Epub 2008 Aug 31.